CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 311 enrolled
Drug / intervention
Non Interventional Observationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00858143
NCT00858143N/ACompleted
CompareCT.gov

German Non Interventional Study For Patients Treated With Somavert®

Pfizer·observational·Posted Mar 9, 2009·Updated Sep 2, 2009

In Brief

An observational study evaluating Non Interventional Observation for Acromegaly. Completed, enrolled 311 participants.

Detailed Summary

This open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study was performed in order to examine the efficacy and safety of Somavert® in treatment of subjects with acromegaly and its effects on acromegaly related co-morbidities.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcromegaly
Countries--
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 9, 2009
Enrollment StartJan 1, 2004
Primary CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 17.3 years ago

Interventions

Non Interventional Observationother

Post marketing surveillance study = prospective, non-interventional observation of the use of Somavert®